<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32206784</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>143</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications.</ArticleTitle><Pagination><StartPage>1651</StartPage><EndPage>1673</EndPage><MedlinePgn>1651-1673</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awaa022</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is the most common degenerative disorder of motor neurons in adults. As there is no cure, thousands of individuals who are alive at present will succumb to the disease. In recent years, numerous causative genes and risk factors for amyotrophic lateral sclerosis have been identified. Several of the recently identified genes encode kinases. In addition, the hypothesis that (de)phosphorylation processes drive the disease process resulting in selective motor neuron degeneration in different disease variants has been postulated. We re-evaluate the evidence for this hypothesis based on recent findings and discuss the multiple roles of kinases in amyotrophic lateral sclerosis pathogenesis. We propose that kinases could represent promising therapeutic targets. Mainly due to the comprehensive regulation of kinases, however, a better understanding of the disturbances in the kinome network in amyotrophic lateral sclerosis is needed to properly target specific kinases in the clinic.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wenting</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven-Stem Cell Institute (SCIL), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandoorne</LastName><ForeName>Tijs</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyaert</LastName><ForeName>Jolien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staats</LastName><ForeName>Kim A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Regenerative Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.-</RegistryNumber><NameOfSubstance UI="D011494">Protein Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011494" MajorTopicYN="N">Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">kinase</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">phosphorylation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32206784</ArticleId><ArticleId IdType="pmc">PMC7296858</ArticleId><ArticleId IdType="doi">10.1093/brain/awaa022</ArticleId><ArticleId IdType="pii">5811091</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackerley S, Grierson AJ, Banner S, Perkinton MS, Brownlees J, Byers HL, et al.p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci 2004; 26: 354&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">15207859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad L, Zhang S-Y, Casanova J-L, Sancho-Shimizu V.. Human TBK1: a Gatekeeper of Neuroinflammation. Trends Mol. Med 2016; 22: 511&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890605</ArticleId><ArticleId IdType="pubmed">27211305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn S-W, Jeon GS, Kim M-J, Shon J-H, Kim J-E, Shin J-Y, et al.Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis. J Neurol Sci 2014; 340: 112&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24680562</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Allen C, Counsell C, Farrin A, Dickie B, Kelly J, et al.Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2013; 12: 339&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3610091</ArticleId><ArticleId IdType="pubmed">23453347</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander EJ, Ghanbari Niaki A, Zhang T, Sarkar J, Liu Y, Nirujogi RS, et al.Ubiquilin 2 modulates ALS/FTD-linked FUS&#x2013;RNA complex dynamics and stress granule formation. Proc Natl Acad Sci U S A 2018; 115: E11485&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Logroscino G, Jick SS, Hern&#xe1;n MA.. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol 2009; 16: 745&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093130</ArticleId><ArticleId IdType="pubmed">19475756</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparicio R, Rana A, Walker DW.. Upregulation of the autophagy adaptor p62/SQSTM1 prolongs health and lifespan in middle-aged Drosophila. Cell Rep 2019; 28: 1029&#x2013;40.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6688777</ArticleId><ArticleId IdType="pubmed">31340141</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al.TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Fay MM, Lyons SM, Achorn CA, Kedersha N, Anderson P, et al.Stress-specific differences in assembly and composition of stress granules and related foci. J Cell Sci 2017; 130: 927&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5358336</ArticleId><ArticleId IdType="pubmed">28096475</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker MR. ALS&#x2013;dying forward, backward or outward? Nat Rev Neurol 2014; 10: 660..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4221249</ArticleId><ArticleId IdType="pubmed">25245152</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa LF, Cerqueira FM, Macedo AFA, Garcia CCM, Angeli JPF, Schumacher RI, et al.Increased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS. Biochim Biophys Acta 2010; 1802: 462&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">20097285</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, et al.Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 2011; 134: 1293&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3097891</ArticleId><ArticleId IdType="pubmed">21596768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, Atzori C, Piva R, Tortarolo M, Strong MJ, DeBiasi S, et al.Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice. J Neuropathol Exp Neurol 2004; 63: 113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14989597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhullar KS, Lagar&#xf3;n NO, McGowan EM, Parmar I, Jha A, Hubbard BP, et al.Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer 2018; 17: 48..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5817855</ArticleId><ArticleId IdType="pubmed">29455673</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJN, Koppers M, van den Berg LH, Pasterkamp RJ.. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 2013; 125: 777&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Alberti S, Fawzi NL, Mittag T, Polymenidou M, Rousseau F, et al.Protein phase separation: a new phase in cell biology. Trends Cell Biol 2018; 28: 420&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6034118</ArticleId><ArticleId IdType="pubmed">29602697</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Kovacs D, Konijnenberg A, Timmerman E, Volkov A, et al.Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol Cell 2017; 65: 1044&#x2013;55.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Gitler AD.. Phosphorylation leads the way for protein aggregate disassembly. Dev Cell 2018; 45: 279&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">29738705</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E, Boeynaems S, Kato M, Guo L, Caulfield TR, Steyaert J, et al.Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity. Cell Rep 2018; 24: 529&#x2013;37.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady ST, Morfini GA.. Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases. Neurobiol Dis 2017; 105: 273&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5522763</ArticleId><ArticleId IdType="pubmed">28411118</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Muller K, Wieland T, Weydt P, Bohm S, Lule D, et al.NEK1 mutations in familial amyotrophic lateral sclerosis. Brain 2016; 139: e28..</Citation><ArticleIdList><ArticleId IdType="pubmed">26945885</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell MC, Meier E S, Ingram AL, Abisambra JF.. PERK-opathies: an endoplasmic reticulum stress mechanism underlying neurodegeneration. Car 2016; 13: 150&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6542591</ArticleId><ArticleId IdType="pubmed">26679859</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M-L, Garc&#xed;a-Ayll&#xf3;n M-S, Ciura S, S&#xe1;ez-Valero J, Kabashi E.. Neuromuscular junction impairment in amyotrophic lateral sclerosis: reassessing the role of acetylcholinesterase. Front Mol Neurosci 2016; 9: 160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5187284</ArticleId><ArticleId IdType="pubmed">28082868</ArticleId></ArticleIdList></Reference><Reference><Citation>Casci I, Pandey UB.. A fruitful endeavor: modeling ALS in the fruit fly. Brain Res 2015; 1607: 47&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4385417</ArticleId><ArticleId IdType="pubmed">25289585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Baloh RH, Milbrandt J.. The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons. J Cell Sci 2009; 122: 2274&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2723145</ArticleId><ArticleId IdType="pubmed">19509051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheah BC, Vucic S, Krishnan A, Kiernan MC.. Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 2010; 17: 1942&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">20377511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N-F, Chen W-F, Sung C-S, Lu C-H, Chen C-L, Hung H-C, et al.Contributions of p38 and ERK to the antinociceptive effects of TGF-&#x3b2;1 in chronic constriction injury-induced neuropathic rats. J Headache Pain 2016; 17: 72..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4991976</ArticleId><ArticleId IdType="pubmed">27541934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Craigen WJ, Riley DJ.. Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1. Cell Cycle 2009; 8: 257&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673983</ArticleId><ArticleId IdType="pubmed">19158487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Deng J, Wang P, Yang M, Chen X, Zhu L, et al.PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration. Hum Mol Genet 2016; 25: 5059&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078632</ArticleId><ArticleId IdType="pubmed">27794540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guan Y, Liu H, Wu X, Yu L, Wang S, et al.Activation of the Wnt/&#x3b2;-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem Biophys Res Commun 2012; 420: 397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">22426476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitiprolu M, Jagow C, Tremblay V, Bondy-Chorney E, Paris G, Savard A, et al.A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy. Nat Commun 2018; 9: 2794..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052026</ArticleId><ArticleId IdType="pubmed">30022074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciani L, Salinas PC.. c-Jun N-terminal kinase (JNK) cooperates with Gsk3beta to regulate dishevelled-mediated microtubule stability. BMC Cell Biol 2007; 8: 27..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1940000</ArticleId><ArticleId IdType="pubmed">17608927</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al.Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 2015; 347: 1436&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Aizer A, Shav-Tal Y, Yanai A, Motro B.. Nek7 kinase accelerates microtubule dynamic instability. Biochim Biophys Acta-Mol Cell Res 2013; 1833: 1104&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">23313050</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz VH, Brekken RA.. Assessment of TANK-binding kinase 1 as a therapeutic target in cancer. J Cell Commun Signal 2018; 12: 83&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5842199</ArticleId><ArticleId IdType="pubmed">29218456</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D.. The &#x2018;dying-back&#x2019; phenomenon of motor neurons in ALS. J Mol Neurosci 2011; 43: 470&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBerg HA, Blehm BH, Sheung J, Thompson AR, Bookwalter CS, Torabi SF, et al.Motor domain phosphorylation modulates kinesin-1 transport. J Biol Chem 2013; 288: 32612&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820893</ArticleId><ArticleId IdType="pubmed">24072715</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al.Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>de Majo M, Topp SD, Smith BN, Nishimura AL, Chen H-J, Gkazi AS, et al.ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol Aging 2018; 71: 266.e1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6983933</ArticleId><ArticleId IdType="pubmed">30033073</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q, Holler CJ, Taylor G, Hudson KF, Watkins W, Gearing M, et al.FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J Neurosci 2014; 34: 7802&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4044245</ArticleId><ArticleId IdType="pubmed">24899704</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, Hafezparast M.. Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research? Neurobiol Dis 2017; 105: 283&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewil M, Dela Cruz VF, Van Den Bosch L, Robberecht W.. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol Dis 2007; 26: 332&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">17346981</ArticleId></ArticleIdList></Reference><Reference><Citation>DiSabato DJ, Quan N, Godbout JP.. Neuroinflammation: the devil is in the details. J Neurochem 2016; 139: 136&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5025335</ArticleId><ArticleId IdType="pubmed">26990767</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, et al.ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 2010; 29: 2841&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J, Wei Y, Liu L, Wang Y, Khairova R, Blumenthal R, et al.A kinesin signaling complex mediates the ability of GSK-3 to affect mood-associated behaviors. Proc Natl Acad Sci U S A 2010; 107: 11573&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2895136</ArticleId><ArticleId IdType="pubmed">20534517</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, Guo M, Yi L, Zhang J, Bi Y, Liu Y, et al.Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD&#x2010;ALS in mice. Aging 2019; 11: 2457&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6519994</ArticleId><ArticleId IdType="pubmed">31039129</ArticleId></ArticleIdList></Reference><Reference><Citation>Emara MM, Ivanov P, Hickman T, Dawra N, Tisdale S, Kedersha N, et al.Angiogenin-induced tRNA-derived stress-induced RNAs promote stress-induced stress granule assembly. J Biol Chem 2010; 285: 10959&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856301</ArticleId><ArticleId IdType="pubmed">20129916</ArticleId></ArticleIdList></Reference><Reference><Citation>Endow SA. Determinants of molecular motor directionality. Nat Cell Biol 1999; 1: E163&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10559980</ArticleId></ArticleIdList></Reference><Reference><Citation>Engmann O, Giese KP.. Crosstalk between Cdk5 and GSK3beta: implications for Alzheimer&#x2019;s disease. Front Mol Neurosci 2009; 2: 2..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2694676</ArticleId><ArticleId IdType="pubmed">19521544</ArticleId></ArticleIdList></Reference><Reference><Citation>Eto K, Hommyo A, Yonemitsu R, Abe S.. ErbB4 signals Neuregulin1-stimulated cell proliferation and c-fos gene expression through phosphorylation of serum response factor by mitogen-activated protein kinase cascade. Mol Cell Biochem 2010; 339: 119&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">20066477</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Lin H, Wang X, Zuo Q, Qin J, Zhang P.. The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair. Acta Biochim Biophys Sin (Shanghai) 2015; 47: 834&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4581587</ArticleId><ArticleId IdType="pubmed">26290490</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Sundaramoorthy V, Sultana JM, Yang S, Atkinson RAK, Levina V, et al.C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet 2014; 23: 3579&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al.SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 2011; 68: 1440&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige E, Shalom O, Tsuriel S, Yissachar N, Motro B.. Nek1 shares structural and functional similarities with NIMA kinase. Biochim Biophys Acta-Mol Cell Res 2006; 1763: 272&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">16603261</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H-L, Leng Y, Ma C-H, Zhang J, Ren M, Chuang D-M.. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 2008; 155: 567&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2709275</ArticleId><ArticleId IdType="pubmed">18640245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson FM, Gray NS.. Kinase inhibitors: the road ahead. Nat Rev Drug Discov 2018; 17: 353&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">29545548</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes N, Eshleman N, Buchan JR.. Stress granules and ALS: a case of causation or correlation? Adv Neurobiol 2018; 173&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">29916020</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, et al.Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2008; 105: 2052&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2538879</ArticleId><ArticleId IdType="pubmed">18250315</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xfc;ller K, et al.Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 2015; 18: 631&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry AM, O&#x2019;Regan L, Sabir SR, Bayliss R.. Cell cycle regulation by the NEK family of protein kinases. J Cell Sci 2012; 125: 4423&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3500863</ArticleId><ArticleId IdType="pubmed">23132929</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa T, Takahashi M, Tsukamoto Y, Yamaguchi N, Nakoji M, Endo M, et al.The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet 2016; 25: 245&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26604152</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumoto K, Hoogenraad CC, Kikuchi A.. GSK-3beta-regulated interaction of BICD with dynein is involved in microtubule anchorage at centrosome. EMBO J 2006; 25: 5670&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1698904</ArticleId><ArticleId IdType="pubmed">17139249</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FJ, Hebbar S, Gao XA, Alexander M, Pandey JP, Walla MD, et al.GSK-3&#x3b2; phosphorylation of cytoplasmic dynein reduces ndel1 binding to intermediate chains and alters dynein motility. Traffic 2015; 16: 941&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4543430</ArticleId><ArticleId IdType="pubmed">26010407</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia D, Shaw RJ.. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell 2017; 66: 789&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5553560</ArticleId><ArticleId IdType="pubmed">28622524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs KL, Kalmar B, Rhymes ER, Fellows AD, Ahmed M, Whiting P, et al.Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis 2018; 9: 596..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964181</ArticleId><ArticleId IdType="pubmed">29789529</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, et al.TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 2008; 63: 535&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Shorter J.. RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 2011; 5: 179&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3226045</ArticleId><ArticleId IdType="pubmed">21847013</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldshmit Y, Galea MP, Wise G, Bartlett PF, Turnley AM.. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 2004; 24: 10064&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6730186</ArticleId><ArticleId IdType="pubmed">15537875</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein O, Kedmi M, Gana-Weisz M, Twito S, Nefussy B, Vainer B, et al.Rare homozygosity in amyotrophic lateral sclerosis suggests the contribution of recessive variants to disease genetics. J Neurol Sci 2019; 402: 62&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31108397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Fern&#xe1;ndez C, Gonzalez P, Andres-Benito P, Ferrer I, Rodr&#xed;guez FJ.. Wnt signaling alterations in the human spinal cord of amyotrophic lateral sclerosis cases: spotlight on Fz2 and Wnt5a. Mol Neurobiol 2019; 56: 6777&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">30924074</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A, Butler K, Long J, Cavey J, Scott D, Shaw B, et al.Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy 2016; 12: 1094&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4990988</ArticleId><ArticleId IdType="pubmed">27158844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratten J, Zhao Q, Benyamin B, Garton F, He J, Leo PJ, et al.Whole-exome sequencing in amyotrophic lateral sclerosis suggests NEK1 is a risk gene in Chinese. Genome Med 2017; 9: 97..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693798</ArticleId><ArticleId IdType="pubmed">29149916</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Macleod GT, Wellington A, Hu F, Panchumarthi S, Schoenfield M, et al.The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 2005; 47: 379&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055062</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Naujock M, Fumagalli L, Vandoorne T, Baatsen P, Boon R, et al.HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun 2017; 8: 861..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Stoklund Dittlau K, Van Den Bosch L.. Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications. Semin Cell Dev Biol 2019. doi: 10.1016/j.semcdb.2019.07.010.</Citation><ArticleIdList><ArticleId IdType="pubmed">31542222</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M, Pu H, Chiu A.. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Mitsui S, Pan L, Otomo A, Kubo M, Sato K, et al.Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hum Mol Genet 2016; 25: 3321&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">27439389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond TR, Marsh SE, Stevens B.. Immune signaling in neurodegeneration. Immunity 2019; 50: 955&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6822103</ArticleId><ArticleId IdType="pubmed">30995509</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanada T, Weitzer S, Mair B, Bernreuther C, Wainger BJ, Ichida J, et al.CLP1 links tRNA metabolism to progressive motor-neuron loss. Nature 2013; 495: 474&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674495</ArticleId><ArticleId IdType="pubmed">23474986</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al.Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 2008; 64: 60&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa J, Strunk BS, Weisman LS.. PI5P and PI(3,5)P2: minor, but essential phosphoinositides. Cell Struct Funct 2017; 42: 49&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846621</ArticleId><ArticleId IdType="pubmed">28302928</ArticleId></ArticleIdList></Reference><Reference><Citation>Havali-Shahriari Z, Weinfeld M, Glover J.. Characterization of DNA substrate binding to the phosphatase domain of the DNA repair enzyme polynucleotide kinase/phosphatase. Biochemistry 2017; 56: 1737&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5469602</ArticleId><ArticleId IdType="pubmed">28276686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, Chami AA, de Assis DR, Vourc&#x2019;h P, Andres CR, Corcia P, et al.The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain 2019; 142: 1176&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman M, Ciancanelli M, Ou Y-H, Lorenzo L, Klaudel-Dreszler M, Pauwels E, et al.Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med 2012; 209: 1567&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428952</ArticleId><ArticleId IdType="pubmed">22851595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Mollereau B.. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 2014; 15: 233&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">24619348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Saxena S.. ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol 2017; 13: 477&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">28731040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hida T, Nakamura F, Usui H, Takeuchi K, Yamashita N, Goshima Y.. Semaphorin3A-induced axonal transport mediated through phosphorylation of Axin-1 by GSK3&#x3b2;. Brain Res 2015; 1598: 46&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">25528666</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J, Catanese A, Semelink-Sedlacek LL, Oeztuerk S, Lutz A-K, Bausinger J, et al.NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res 2018; 30: 150&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">29929116</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi D, Collins CA, Bhat P, Barkus RV, Diantonio A, Saxton WM.. Control of a kinesin-cargo linkage mechanism by JNK pathway kinases. Curr Biol 2007; 17: 1313&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2041807</ArticleId><ArticleId IdType="pubmed">17658258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J-H, Zhang H, Wagey R, Krieger C, Pelech SL.. Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J Neurochem 2003; 85: 432&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">12675919</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Huang Q, Su H, Mai X, Feng E, Cao Z, et al.TAR DNA-binding protein 43 inhibits inflammatory response and protects chondrocyte function by modulating RACK1 expression in osteoarthritis. Biomed Pharmacother 2017; 85: 362&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">27890430</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Zhang Z, Qin F, Tang W, Liu D, Wu P, et al.The mechanism of TDP&#x2010;43 gene expression on inflammatory factors and the JNK and p38 MAPK signalling pathways in ischaemic hypoxic stress dependence. Int Wound J 2019; 16: 724&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30784197</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphries F, Yang S, Wang B, Moynagh PN.. RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ 2015; 22: 225&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4291486</ArticleId><ArticleId IdType="pubmed">25146926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynes NE, Lane HA.. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005; 5: 341&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">15864276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomov OC, Sbrissa D, Delvecchio K, Xie Y, Jin J-P, Rappolee D, et al.The phosphoinositide kinase PIKfyve is vital in early embryonic development. J Biol Chem 2011; 286: 13404&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3075686</ArticleId><ArticleId IdType="pubmed">21349843</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, et al.The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci Transl Med 2017; 9: eaaf3962..</Citation><ArticleIdList><ArticleId IdType="pubmed">28539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, et al.RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 2016; 353: 603&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametaka S, Moriyama K, Burgos PV, Eisenberg E, Greene LE, Mattera R, et al.Canonical interaction of cyclin G associated kinase with adaptor protein 1 regulates lysosomal enzyme sorting. MBoC 2007; 18: 2991&#x2013;3001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1949374</ArticleId><ArticleId IdType="pubmed">17538018</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsumata R, Ishigaki S, Katsuno M, Kawai K, Sone J, Huang Z, et al.c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. PLoS One 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3458026</ArticleId><ArticleId IdType="pubmed">23049975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PTC, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, et al.NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet 2016; 48: 1037&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H, Almer G, Yamashita S, Guegan C, Nagai M, Xu Z, et al.Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci U S A 2006; 103: 6025&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1458691</ArticleId><ArticleId IdType="pubmed">16595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Kim T-Y, Cho K-S, Kim HN, Koh J-Y.. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis 2013; 59: 80&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23891729</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-J, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, et al.Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet 2014; 46: 152&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Taylor JP.. Lost in transportation: nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases. Neuron 2017; 96: 285&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinman E, Holzbaur E.. Stress-induced CDK5 activation disrupts axonal transport via Lis1/Ndel1/Dynein. Cell Rep 2015; 12: 462&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532378</ArticleId><ArticleId IdType="pubmed">26166569</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinman E, Tokito M, Holzbaur E.. CDK5-dependent activation of dynein in the axon initial segment regulates polarized cargo transport in neurons. Traffic 2017; 18: 808&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5683723</ArticleId><ArticleId IdType="pubmed">28941293</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh S-H, Kim Y, Kim HY, Hwang S, Lee CH, Kim SH.. Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS. Exp Neurol 2007; 205: 336&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">17433298</ArticleId></ArticleIdList></Reference><Reference><Citation>Koskim&#xe4;ki J, Zhang D, Li Y, Saadat L, Moore T, Lightle R, et al.Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations. Acta Neuropathol Commun 2019; 7: 132..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6699077</ArticleId><ArticleId IdType="pubmed">31426861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N, Pal A, Lojewski X, Corcia P, Naujock M, Reinhardt P, et al.Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol Dis 2018; 115: 167&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger C, Hu JH, Pelech S.. Aberrant protein kinases and phosphoproteins in amyotrophic lateral sclerosis. Trends Pharmacol Sci 2003; 24: 535&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">14559406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Bosco D. A, Leclerc A L, Tamrazian E, Vanderburg CR, Russ C, et al.Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323: 1205&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon YT, Ciechanover A.. The ubiquitin code in the ubiquitin-proteasome system and autophagy. Trends Biochem Sci 2017; 42: 873&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">28947091</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Cleveland DW.. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 2010; 19: R46&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasiene J, Komine O, Fujimori-Tonou N, Powers B, Endo F, Watanabe S, et al.Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Acta Neuropathol Commun 2016; 4: 15..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758105</ArticleId><ArticleId IdType="pubmed">26891847</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal-Lasarte MM, Franco JM, Labrador-Garrido A, Pozo D, Roodveldt C.. Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia. FASEB J 2017; 31: 2797&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pubmed">28336525</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pichon CE, Dominguez SL, Solanoy H, Ngu H, Lewin-Koh N, Chen M, et al.EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS. PLoS One 2013; 8: e62342..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637182</ArticleId><ArticleId IdType="pubmed">23638043</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pichon CE, Meilandt WJ, Dominguez S, Solanoy H, Lin H, Ngu H, et al.Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci Transl Med 2017; 9: eaag0394..</Citation><ArticleIdList><ArticleId IdType="pubmed">28814543</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H-R, Chiang W-C, Chou P-C, Wang W-J, Huang J.. TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues. J Biol Chem 2018; 293: 6090&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5912450</ArticleId><ArticleId IdType="pubmed">29511089</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Xu D, Wang Y, Zhou Z, Liu J, Hu S, et al.Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation. Autophagy 2018; 14: 66&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846504</ArticleId><ArticleId IdType="pubmed">29394115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling KK, Jackson M, Alkam D, Liu D, Allaire N, Sun C, et al.Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis. Neurobiol. Dis 2018; 114: 174&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">29518482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW.. Converging mechanisms in als and FTD: disrupted RNA and protein homeostasis. Neuron 2013; 79: 416&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingor P, Weber M, Camu W, Friede T, Hilgers R, Leha A, et al.ROCK-ALS: protocol for a randomized, placebo-controlled, double-blind phase IIa trial of safety, tolerability and efficacy of the rho kinase (ROCK) inhibitor fasudil in amyotrophic lateral sclerosis. Front Neurol 2019; 10: 293..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6446974</ArticleId><ArticleId IdType="pubmed">30972018</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-J, Ju T-C, Chen H-M, Jang Y-S, Lee L-M, Lai H-L, et al.Activation of AMP-activated protein kinase &#x3b1;1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis. Hum Mol Genet 2015; 24: 787&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">25256353</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wang F.. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol 2017; 8: 1005..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokireddy S, Kukushkin NV, Goldberg AL.. cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins. Proc Natl Acad Sci U S A 2015; 112: E7176&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702992</ArticleId><ArticleId IdType="pubmed">26669444</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez E, Casasnovas C, Gim&#xe9;nez J, Santamar&#xed;a R, Terrazas JM, Volpini V.. Identification of two novel KIF5A mutations in hereditary spastic paraplegia associated with mild peripheral neuropathy. J Neurol Sci 2015; 358: 422&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26403765</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Dom&#xe9;nech G, Covill-Cooke C, Ivankovic D, Halff EF, Sheehan DF, Norkett R, et al.Miro proteins coordinate microtubule- and actin-dependent mitochondrial transport and distribution. EMBO J 2018; 37: 321&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793800</ArticleId><ArticleId IdType="pubmed">29311115</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J, Tadokoro T, Baughn MW, Myers B, McAlonis-Downes M, Chillon-Marinas C, et al.ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron 2018; 100: 816&#x2013;30.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Font I, Sogorb-Esteve A, Javier-Torrent M, Brinkmalm G, Herrando-Grabulosa M, Garc&#xed;a-Lareu B, et al.Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis. Neurobiol Dis 2019; 124: 428&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">30594809</ArticleId></ArticleIdList></Reference><Reference><Citation>MacAskill AF, Rinholm JE, Twelvetrees AE, Arancibia-Carcamo IL, Muir J, Fransson A, et al.Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 2009; 61: 541&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2670979</ArticleId><ArticleId IdType="pubmed">19249275</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Rademakers R, Neumann M.. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010; 9: 995&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Mart&#xed;nez-Muriana A, Leiva T, Gregorio D, Ariza L, Morell M, et al.Neuregulin-1 promotes functional improvement by enhancing collateral sprouting in SOD1G93A ALS mice and after partial muscle denervation. Neurobiol Dis 2016; 95: 168&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">27461051</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovinovic A, Cimbro R, Ljutic T, Kriz J, Rogelj B, Munitic I.. Optineurin in amyotrophic lateral sclerosis: multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms. Prog Neurobiol 2017; 154: 1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28456633</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G, Shimogori T, Hattori N, Nukina N.. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet 2015; 24: 4429&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">25972374</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH.. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol 2019; 137: 715&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas DB, Gonz&#xe1;lez JV, Falcon P, Hetz C.. Fine-tuning ER stress signal transducers to treat amyotrophic lateral sclerosis. Front Mol Neurosci 2017; 10: 216..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496948</ArticleId><ArticleId IdType="pubmed">28725179</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo-Hanchuk TD, Slepicka PF, Meirelles GV, Basei FL, Lovato DV, Granato DC, et al.NEK1 kinase domain structure and its dynamic protein interactome after exposure to. Sci Rep 2017; 7: 5445..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5511132</ArticleId><ArticleId IdType="pubmed">28710492</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf2;dol-Caballero G, Santos D, Navarro X, Herrando-Grabulosa M.. Neuregulin 1 reduces motoneuron cell death and promotes neurite growth in an in vitro model of motoneuron degeneration. Front Cell Neurosci 2017; 11: 431..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5767462</ArticleId><ArticleId IdType="pubmed">29375317</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore AS, Holzbaur E.. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci U S A 2016; 113: E3349&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4914160</ArticleId><ArticleId IdType="pubmed">27247382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora JS, Genge A, Chio A, Estol CJ, Chaverri D, Hern&#xe1;ndez M, et al.Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotroph Lateral Scler Frontotemporal Degener 2019; 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">31280619</ArticleId></ArticleIdList></Reference><Reference><Citation>Morano M, Ronchi G, Nicol&#xf2; V, Fornasari BE, Crosio A, Perroteau I, et al.Modulation of the Neuregulin 1/ErbB system after skeletal muscle denervation and reinnervation. Sci Rep 2018; 8: 5047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5864756</ArticleId><ArticleId IdType="pubmed">29568012</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G, Spampinato AG, Cavallaro S.. Neuroinflammation and ALS: transcriptomic insights into molecular disease mechanisms and therapeutic targets. Mediators Inflamm 2017; 2017: 7070469..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610842</ArticleId><ArticleId IdType="pubmed">29081603</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini GA, Bosco DA, Brown H, Gatto R, Kaminska A, Song Y, et al.Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS One 2013; 8: e65235..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3680447</ArticleId><ArticleId IdType="pubmed">23776455</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, et al.Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun 2018; 9: 335..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen MD, Larivi&#xe8;re RC, Julien JP.. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001; 30: 135&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">11343650</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J.. ALS genes in the genomic era and their implications for FTD. Trends Genet 2018; 34: 404&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Mossevelde S, Dillen L, De Bleecker JL, Moisse M, Van Damme P, et al.NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients. Neurobiol Aging 2018; 61: 255.e1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28935222</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie S-D, Li X, Tang C-E, Min F-Y, Shi X-J, Wu L-Y, et al.High glucose forces a positive feedback loop connecting ErbB4 expression and mTOR/S6K pathway to aggravate the formation of tau hyperphosphorylation in differentiated SH-SY5Y cells. Neurobiol Aging 2018; 67: 171&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">29674181</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwadike C, Williamson LE, Gallagher LE, Guan J-L, Chan E.. AMPK inhibits ULK1-dependent autophagosome formation and lysosomal acidification via distinct mechanisms. Mol Cell Biol 2018; 38: e00023-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5954193</ArticleId><ArticleId IdType="pubmed">29507183</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes JA, Davies MC, Collins MO.. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain 2017; 10: 5..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Gendron TF, Staff NP.. Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc 2018; 93: 1617&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Paatero I, Veikkolainen V, M&#xe4;enp&#xe4;&#xe4; M, Schmelzer E, Belting HG, Pelliniemi LJ, et al.ErbB4 tyrosine kinase inhibition impairs neuromuscular development in zebrafish embryos. Mol Biol Cell 2019; 30: 209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6589560</ArticleId><ArticleId IdType="pubmed">30462579</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A, Gla&#xdf; H, Naumann M, Kreiter N, Japtok J, Sczech R, et al.High content organelle trafficking enables disease state profiling as powerful tool for disease modelling. Sci Data 2018; 5: 180241..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6233479</ArticleId><ArticleId IdType="pubmed">30422121</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey JP, Smith DS.. A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J Neurosci 2011; 31: 17207&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3249231</ArticleId><ArticleId IdType="pubmed">22114287</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, et al.A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 2015; 162: 1066&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera ND, Sheean RK, Scott JW, Kemp BE, Horne MK, Turner BJ.. Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models. PLoS One 2014; 9: e90449..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3942426</ArticleId><ArticleId IdType="pubmed">24595038</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C, Bieniek KF, Finch N, van de Vorst M, Baker M, Perkersen R, et al.Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol 2015; 130: 77&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE.. Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 2009; 78: 959&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">19298183</ArticleId></ArticleIdList></Reference><Reference><Citation>Prior R, Van Helleputte L, Benoy V, Van Den Bosch L.. Defective axonal transport: a common pathological mechanism in inherited and acquired peripheral neuropathies. Neurobiol Dis 2017; 105: 300&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28238949</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, Tarrant MK, Choi SH, Sathyamurthy A, Bose R, Banjade S, et al.Mechanism of activation and inhibition of the HER4/ErbB4 Kinase. Structure 2008; 16: 460&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2858219</ArticleId><ArticleId IdType="pubmed">18334220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, Pandey UB.. Autophagy dysregulation in ALS: when protein aggregates get out of hand. Front Mol Neurosci 2017; 10: 263..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin CA, Sun Q, Gamblin TC.. Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol Neurodegener 2007; 2: 12..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1936422</ArticleId><ArticleId IdType="pubmed">17598919</ArticleId></ArticleIdList></Reference><Reference><Citation>Rask-Andersen M, Zhang J, Fabbro D, Schi&#xf6;th HB.. Advances in kinase targeting: current clinical use and clinical trials. Trends Pharmacol. Sci 2014; 35: 604&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">25312588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Buratti E.. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J Neurochem 2016; 138: 95&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Reck-Peterson SL, Redwine WB, Vale RD, Carter AP.. The cytoplasmic dynein transport machinery and its many cargoes. Nat Rev Mol Cell Biol 2018; 19: 382&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457270</ArticleId><ArticleId IdType="pubmed">29662141</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ.. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 2014; 17: 17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al.A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads SN, Monahan ZT, Yee DS, Leung AY, Newcombe CG, O&#x2019;Meally RN, et al.The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization. MBoC 2018; 29: 1786&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6085830</ArticleId><ArticleId IdType="pubmed">29897835</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter B, Sliter DA, Herhaus L, Stolz A, Wang C, Beli P, et al.Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci U S A 2016; 113: 4039&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839414</ArticleId><ArticleId IdType="pubmed">27035970</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi L, Sepe M, Donne RD, Feliciello A.. A dynamic interface between ubiquitylation and cAMP signaling. Front Pharmacol 2015; 6: 177..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4559665</ArticleId><ArticleId IdType="pubmed">26388770</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al.Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ru&#xe9; L, Oeckl P, Timmers M, Lenaerts A, van der Vos J, Smolders S, et al.Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis. Acta Neuropathol Commun 2019; 7: 114..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6626434</ArticleId><ArticleId IdType="pubmed">31300041</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo GJ, Louie K, Wellington A, Macleod GT, Hu F, Panchumarthi S, et al.Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport. J Neurosci 2009; 29: 5443&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693725</ArticleId><ArticleId IdType="pubmed">19403812</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A, Scardigli R, La Regina F, Murray ME, Romano N, Dickson DW, et al.Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes. Hum Mol Genet 2017; 26: 1407&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075552</ArticleId><ArticleId IdType="pubmed">28158562</ArticleId></ArticleIdList></Reference><Reference><Citation>Salado IG, Redondo M, Bello ML, Perez C, Liachko NF, Kraemer BC, et al.Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. J Med Chem 2014; 57: 2755&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969104</ArticleId><ArticleId IdType="pubmed">24592867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RRK, Fallini C, Gatto R, McKeon JE, Song Y, Rotunno MS, et al.ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci Rep 2017; 7: 115..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428330</ArticleId><ArticleId IdType="pubmed">28273913</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton WM, Hollenbeck PJ.. The axonal transport of mitochondria. J Cell Sci 2012; 125: 2095&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656622</ArticleId><ArticleId IdType="pubmed">22619228</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaffer AE, Eggens VRC, Caglayan AO, Reuter MS, Scott E, Coufal NG, et al.CLP1 founder mutation links tRNA splicing and maturation to cerebellar development and neurodegeneration. Cell 2014; 157: 651&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4128918</ArticleId><ArticleId IdType="pubmed">24766810</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoonaert L, Ru&#xe9; L, Roucourt B, Timmers M, Little S, Ch&#xe1;vez-Guti&#xe9;rrez L, et al.Identification and characterization of Nanobodies targeting the EphA4 receptor. J Biol Chem 2017; 292: 11452&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5500810</ArticleId><ArticleId IdType="pubmed">28526745</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y, Huang EJ.. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res 2016; 1647: 65&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003642</ArticleId><ArticleId IdType="pubmed">27033831</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea TB, Yabe JT, Ortiz D, Pimenta A, Loomis P, Goldman RD, et al.Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J Cell Sci 2004; 117: 933&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">14762105</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, Li Y, Chang W-H, Hung S-T, et al.Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med 2018; 24: 313&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J. Liquidizing FUS via prion-like domain phosphorylation. EMBO J 2017; 36: 2925&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641903</ArticleId><ArticleId IdType="pubmed">28963393</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu S, Lei X, Liu F, Cui B, Liu Q, Ding Q, et al.Mutation screening of NEK1 in Chinese ALS patients. Neurobiol Aging 2018; 71: 267.e1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">30093141</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson CL, Al-Chalabi A.. Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Biophys Acta-Mol Basis Dis 2006; 1762: 973&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">16973338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivadasan R, Hornburg D, Drepper C, Frank N, Jablonka S, Hansel A, et al.C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nat Neurosci 2016; 19: 1610&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27723745</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith HL, Mallucci GR.. The unfolded protein response: mechanisms and therapy of neurodegeneration. Brain 2016; 139: 2113&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4958893</ArticleId><ArticleId IdType="pubmed">27190028</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, Chiang P, Wang J, Ravits J, Loeb JA.. Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2012; 71: 104&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3270561</ArticleId><ArticleId IdType="pubmed">22249457</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Nagy M, Ni W, Tyagi NK, Fenton WA, L&#xf3;pez-Gir&#xe1;ldez F, et al.Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm. Proc Natl Acad Sci U S A 2013; 110: 5428&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3619309</ArticleId><ArticleId IdType="pubmed">23509252</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al.TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (80-.) 2008; 319: 1668&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats KA, Hernandez S, Sch&#xf6;nefeldt S, Bento-Abreu A, Dooley J, Van Damme P, et al.Rapamycin increases survival in ALS mice lacking mature lymphocytes. Mol Neurodegener 2013; 8: 31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3847677</ArticleId><ArticleId IdType="pubmed">24025516</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats KA, Seah C, Sahimi A, Wang Y, Koutsodendris N, Lin S, et al. Small molecule inhibition of PIKFYVE kinase rescues gain- and loss-of-function C9ORF72 ALS/FTD disease processes in vivo. bioRxiv 2019:685800.</Citation></Reference><Reference><Citation>Stallings NR, Puttaparthi K, Dowling KJ, Luther CM, Burns DK, Davis K, et al.TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS One 2013; 8: e71793..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3742534</ArticleId><ArticleId IdType="pubmed">23967244</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R, Paillusson S, Gomez-Suaga P, Mitchell JC, Lau DHW, Gray EH, et al. ALS/FTD-associated FUS activates GSK-3&#x3b2; to disrupt the VAPB&#x2013;PTPIP 51 interaction and ER&#x2014;mitochondria associations. EMBO Rep 2016; 17: 1326&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5007559</ArticleId><ArticleId IdType="pubmed">27418313</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica RD, Vos KJ, Paillusson S, Mueller S, Sancho RM, Lau K-F, et al.ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat Commun 2014; 5: 3996..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046113</ArticleId><ArticleId IdType="pubmed">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Duan Y, Qin C, Li J-C, Duan G, Deng X, et al.Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis 2018; 9: 953..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6148241</ArticleId><ArticleId IdType="pubmed">30237395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundvall M, Korhonen A, Vaparanta K, Anckar J, Halkilahti K, Salah Z, et al.Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein. J Biol Chem 2012; 287: 23216&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391121</ArticleId><ArticleId IdType="pubmed">22584572</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Matsuoka M.. The JNK/c-Jun signaling axis contributes to the TDP-43-induced cell death. Mol Cell Biochem 2013; 372: 241&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23001869</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W.. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 2014; 10: 661&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Fukuda Y, Yoshimura J, Toyoda A, Kurppa K, Moritoyo H, et al.ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am J Hum Genet 2013; 93: 900&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW.. Decoding ALS: from genes to mechanism. Nature 2016; 539: 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, Takeda T, Lebon V, Boill&#xe9;e S, Doukour&#xe9; B, Bataillon G, et al.Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol 2013; 125: 511&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">23417734</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R, et al.Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res 2007; 1139: 95&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">17280647</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, et al.Expanded autologous regulatory T-lymphocyte infusions in ALS: a phase I, first-in-human study. Neurol Neuroimmunol Neuroinflamm 2018; 5: e465..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961523</ArticleId><ArticleId IdType="pubmed">29845093</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, Giorgini A, et al.Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 2003; 23: 180&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">12812752</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynis I, De Moraes CG, Raza AS, Liebmann JM, Ritch R, Hood DC.. Prevalence and nature of early glaucomatous defects in the central 10&#xb0; of the visual field. JAMA Ophthalmol 2014; 132: 291..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4204644</ArticleId><ArticleId IdType="pubmed">24407153</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, Ibarburu S, Barreto-N&#xfa;&#xf1;ez R, Babdor J, Maciel TT, Guillo M, et al.Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J Neuroinflamm 2016; 13: 177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Trieu VN, Liu R, Liu XP, Uckun FM.. A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2000; 267: 22&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10623568</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinidad JC, Fischbach GD, Cohen JB.. The Agrin/MuSK signaling pathway is spatially segregated from the neuregulin/ErbB receptor signaling pathway at the neuromuscular junction. J Neurosci 2000; 20: 8762&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773073</ArticleId><ArticleId IdType="pubmed">11102484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K, Gampawar P, Schmidt H, Nagy ZF, Nagy D, Kliv&#xe9;nyi P, et al.Comprehensive genetic analysis of a Hungarian amyotrophic lateral sclerosis cohort. Front Genet 2019; 10: 732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6707335</ArticleId><ArticleId IdType="pubmed">31475037</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhya P, Birkenmeier EH, Birkenmeier CS, Barker JE.. Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice. Proc Natl Acad Sci U S A 2000; 97: 217&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26643</ArticleId><ArticleId IdType="pubmed">10618398</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al.Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 1208&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Goris A, Race V, Hersmus N, Dubois B, Van Den Bosch L, et al.The occurrence of mutations in FUS in a Belgian cohort of patients with familial ALS. Eur J Neurol 2010; 17: 754&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19922450</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al.TBK1 mutation spectrum in an extended european patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis. Hum Mutat 2017; 38: 297&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5324646</ArticleId><ArticleId IdType="pubmed">28008748</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L.. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol 2018; 135: 489&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, Veys K, Guo W, Sicart A, Vints K, Swijsen A, et al.Differentiation but not ALS mutations in FUS rewires motor neuron metabolism. Nat Commun 2019; 10: 4147..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742665</ArticleId><ArticleId IdType="pubmed">31515480</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Jones AR, Sproviero W, Shatunov A, Shaw PJ, Leigh PN, et al.Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. Neurology 2017; 89: 1915&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5664299</ArticleId><ArticleId IdType="pubmed">28978660</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, et al.EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med 2012; 18: 1418&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">22922411</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkova K, Christov A, Kamaluddin Z, Kobalka P, Siddiqui S, Hensley K.. Semaphorin 3A signaling through neuropilin-1 is an early trigger for distal axonopathy in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2014; 73: 702&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4072440</ArticleId><ArticleId IdType="pubmed">24918638</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinet L, Zhedanov A.. A &#x2018;missing&#x2019; family of classical orthogonal polynomials. J Phys A: Math Theor 2011; 44: 085201.</Citation></Reference><Reference><Citation>Vlug AS, Teuling E, Haasdijk ED, French P, Hoogenraad CC, Jaarsma D.. ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation. Eur J Neurosci 2005; 22: 1881&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">16262628</ArticleId></ArticleIdList></Reference><Reference><Citation>Voet D, Voet JG, Pratt CW.. Fundamentals of biochemistry: Life at the molecular level. New York: John Wiley &amp; Sons; 2016.</Citation></Reference><Reference><Citation>Vohnoutka RB, Boumil EF, Liu Y, Uchida A, Pant HC, Shea TB.. Influence of a GSK3&#x3b2; phosphorylation site within the proximal C-terminus of Neurofilament-H on neurofilament dynamics. Biol Open 2017; 6: 1516&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5665472</ArticleId><ArticleId IdType="pubmed">28882840</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk AE, Weishaupt JH, Andersen PM, Ludolph AC, Kubisch C.. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Medgen 2018; 30: 252&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, El-Khamisy SF.. Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia. Brain 2018; 141: 1247&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5917746</ArticleId><ArticleId IdType="pubmed">29584802</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Soo KY, Sundaramoorthy V, Parakh S, Ma Y, Farg MA, et al.ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation. PLoS One 2013; 8: e81170..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3843686</ArticleId><ArticleId IdType="pubmed">24312274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Feng J, Yu J, Chen G.. FKBP12 mediates necroptosis by initiating RIPK1&#x2013;RIPK3&#x2013;MLKL signal transduction in response to TNF receptor 1 ligation. J Cell Sci 2019; 132: jcs227777..</Citation><ArticleIdList><ArticleId IdType="pubmed">31028177</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Guo W, Mitra J, Hegde PM, Vandoorne T, Eckelmann BJ, et al.Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nat Commun 2018; 9: 3683..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Pan J, Chen S-D.. Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson&#x2019;s disease. Prog Neurobiol 2012; 98: 207&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">22709943</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, et al.PINK1 and Parkin target miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011; 147: 893&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3261796</ArticleId><ArticleId IdType="pubmed">22078885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhang HPS.. Transition and autophagic degradation of proteins in development and pathogenesis. Trends Cell Biol 2019; 29: 417&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">30826216</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Shaw PJ, De Vos KJ.. Protein homeostasis in amyotrophic lateral sclerosis: therapeutic opportunities? Front Mol Neurosci 2017; 10: 123..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5411428</ArticleId><ArticleId IdType="pubmed">28512398</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH.. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 2009; 106: 18809&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil R, Laplantine E, G&#xe9;nin P.. Regulation of TBK1 activity by Optineurin contributes to cell cycle-dependent expression of the interferon pathway. Cytokine Growth Factor Rev 2016; 29: 23&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">26976762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenqiang C, Lonskaya I, Hebron ML, Ibrahim Z, Olszewski RT, Neale JH, et al.Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice. Hum Mol Genet 2014; 23: 4960&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24847002</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, Sreedharan J. Amyotrophic lateral sclerosis: recent genetic highlights. Curr Opin Neurol 2016; 29: 557&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">27538057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wloga D, Joachimiak E, Fabczak H.. Tubulin post-translational modifications and microtubule dynamics. Int J Mol Sci 2017; 18: 2207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5666887</ArticleId><ArticleId IdType="pubmed">29065455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, De SK, Kulinich A, Salem AF, Koeppen J, Wang R, et al.Potent and selective EphA4 agonists for the treatment of ALS. Cell Chem Biol 2017; 24: 293&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6522132</ArticleId><ArticleId IdType="pubmed">28196613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Yu W, Kishikawa H, Folkerth RD, Iafrate AJ, Shen Y, et al.Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 2007; 62: 609&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2776820</ArticleId><ArticleId IdType="pubmed">17886298</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Zou Q, Xie X, Liu T, Li HS, Jie Z, et al.The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. J Exp Med 2017; 214: 1493&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5413337</ArticleId><ArticleId IdType="pubmed">28356390</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Jin T, Zhu H, Chen H, Ofengeim D, Zou C, et al.TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell 2018; 174: 1477&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Liang C, Swaminathan K, Herrlinger S, Lai F, Shiekhattar R, et al.A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv 2016; 2: e1601167&#x2013;e1601167..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Liu M, Tian Y, Wang J, Xu Y.. Cryo-EM structure of human DNA-PK holoenzyme. Cell Res 2017; 27: 1341&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5674154</ArticleId><ArticleId IdType="pubmed">28840859</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H, Song S, Pan X.. Knockdown of miR-155 protects microglia against LPS-induced inflammatory injury via targeting RACK1: a novel research for intracranial infection. J Inflamm (Lond) 2017; 14: 17..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549339</ArticleId><ArticleId IdType="pubmed">28804270</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Guan Y, Wu X, Chen Y, Liu Z, Du H, et al.Wnt signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice. Neurochem Res 2013; 38: 1904&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4170800</ArticleId><ArticleId IdType="pubmed">23784673</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Zhou X, Chang M, Nakaya M, Chang J-H, Xiao Y, et al.Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. Nat Commun 2015; 6: 6074..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302769</ArticleId><ArticleId IdType="pubmed">25606824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wang W, Siedlak SL, Liu Y, Liu J, Jiang K, et al.Miro1 deficiency in amyotrophic lateral sclerosis. Front Aging Neurosci 2015; 7: 100..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4443026</ArticleId><ArticleId IdType="pubmed">26074815</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Cooper LT, Boyd AW, Bartlett PF.. Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1G93A ALS mouse model. Sci Rep 2018; 8: 11393..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065374</ArticleId><ArticleId IdType="pubmed">30061574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>